沙美特罗氟替卡松粉吸入剂治疗慢性阻塞性肺疾病的疗效观察  

Clinical Efficacy of Salmeterol and Fluticasone Propionate Inhalation in the Treatment of Chronic Obstructive Pulmonary Disease

作　　者：吴立旭[1] 杨冬梅[1] 

机构地区：[1]川北医学院附属医院呼吸内科,南充市637000

出　　处：《中国药房》2010年第28期2635-2636,共2页China Pharmacy

摘　　要：目的:观察沙美特罗氟替卡松粉吸入剂治疗慢性阻塞性肺疾病(COPD)的疗效。方法:将348例患者随机分为试验组(180例)和对照组(168例),试验组在综合治疗的基础上加用沙美特罗氟替卡松粉吸入剂,每次1吸(50μg沙美特罗、250μg丙酸氟替卡松),bid;对照组仅采用综合疗法,15d为1个疗程。结果:试验组临床症状、肺功能改善明显优于对照组(P<0.05)。结论:沙美特罗氟替卡松粉吸入剂适用于治疗COPD患者,有良好的辅助疗效。OBJECTIVE：To observe clinical efficacy of salmeterol and fluticasone propinate inhalation in the treatment of chronic obstructive pulmonary disease （COPD）.METHODS：348 patients were randomly diuided into trial group（n=180） and control group（n=168）.Both groups received comprehensive treatment for 15 days.Trial group additionally received one time of seretide inhalation twice a day.RESULTS：The clinical symptoms and the improvement of lung function in trial group were superior to in control group obviously.CONCLUSION：Salmeterol and fluticasone propinate inhalation can be applicable to treat COPD and have an ideal assistant effect.

关 键 词：沙美特罗氟替卡松粉吸入剂 慢性阻塞性肺疾病 肺功能 

分 类 号：R974[医药卫生—药品] R56[医药卫生—药学]